ARBK vs HIVE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 07, 2026
ARBK
HIVE
Investment Advisor Scores
HIVE
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ARBK | HIVE | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 100 | 62.8931 | HIVE |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -55.2% | 73.5% | HIVE |
| Earnings Growth | -94.0% | -99.9% | ARBK |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 39.8/100 | 59.7/100 | HIVE |
| Profit Margin | 32.8% | -98.5% | ARBK |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | HIVE |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ARBK
MarkdownPrice below a falling SMA50 (slope -19.0%), weak momentum, RSI 24
HIVE
MarkdownPrice below a falling SMA50 (slope -12.0%), weak momentum, RSI 37
Fundamentals Snapshot
| Metric | ARBK | HIVE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -0.9 | -3.5 |
| Trailing P/E | 0.3 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.6% | 0.7% |
| Gross Margin | 0.2% | 0.4% |
| Operating Margin | -0.4% | -0.6% |
| EPS | 4.97 | -1.32 |
| Dividend Yield | — | — |